RNA干涉技术(RNAi)应用研究进展

RNA干涉是通过双链RNA的介导特异性地降解相应序列的mRNA,从而导致转录后水平的基因沉默,这一过程在拟南芥、线虫和真菌等多种模式植物中发现。RNAi是研究多种生物基因功能的有效手段,本文综述了RNA干涉的分子机理及其应用研究进展。     

RNA干涉的研究进展

生物体内导入双链RNA后会引起体内同源基因特异性的沉默,这种现象称为RNA干涉,本主要介绍RNA干涉的研究历史,作用机制和应用等方面的情况。     

RNA干涉与基因沉默

双链RNA介导的遗传干涉的机制是1998年发现的,它通过双链RNA的介导特异性地降解相应序列的mRNA,从而导致转录后水平的基因沉默,到目前为止的真菌,拟南芥,线虫,锥虫,水螅,涡虫,果蝇,斑马鱼,小鼠等真核生物中都发现存在这一基因沉默机制,目前的研究表明,RNA干涉与植物中的共抑制（Cosuppression),真菌中的基因压制（quelling)很可能具有共同的基本分子机制,这也说明,很可能在进化的很早期阶段,生物就获得了这种机制,RNA干涉对于抵抗病毒入侵,抑制转座子活动等具有重要作用,对于生物体的发育和基因调控可能也有重要作用。     

RNA干涉与干细胞

RNA干涉(RNAi)现象普遍存在于生物体细胞中,在理论上已清楚其分子机制,为干细胞研究提供了新的方法。现从RNAi的分子机制、干细胞中的RNAi现象、研究干细胞RNAi效应的方法以及小分子干涉RNA(siRNA)干涉干细胞特异功能基因的检测方法等方面进行了综述。表明应用RNAi技术研究基因功能和干细胞维持及定向分化的调控具有广阔的发展前景。     

RNA干涉及其应用前景

RNA干涉是指由特定双链RNA(dsRNA)引起的转录后基因沉默现象。研究表明,Dicer断裂dsRNA产生的小干涉RNA可以抑制哺乳动物体细胞和胚胎中的基因的表达。RdRP在扩增RNAi中起着关键性的作用,RdRP活性复制较长的触发性dsRNA或以一种非引物的方式复制短的siRNA,即以siRNA为引物的RdRP反应使靶mRNA转变为dsRNA,同时复制触发性dsRNA。所有的产物又可作为Dicer的底物,起始RdRP级联反应。本文综述了RNAi可能的作用机制,并对RNAi在分析功能基因组、药物治疗等方面的应用前景进行了展望。     

双链RNA在基因沉默中的作用

介绍依赖于同源识别的基因沉默 .依赖于同源识别的基因沉默 ,是指向生物体内导入外源核酸时引起相应序列的内源基因的表达被特异性抑制的一种基因调控现象 .基因沉默分为转录基因沉默和转录后基因沉默 ,二者都通过双链RNA介导 .它们是真核生物中普遍存在的抵抗病毒入侵、抑制转座子活动、调控基因表达的监控机制 .这些机制具有巨大的应用前景 .     

RNA干扰与基因敲除

RNAi是指通过双链RNA介导特异性降解靶mRNA,导致转录后水平基因沉默的现象。其作用途径有RdRP依赖的RNAi的途径与非RdRP依赖的RNAi途径2种。利用RNAi的基因敲除技术在dsRNA序列选择、质粒或病毒为载体的dsRNA体内合成、发夹样siRNA的转录、dsRNA的导入方法等方面取得了很大进展,在研究人类或其他生物基因组中未知基因及蛋白质的功能等领域具有诱人的应用前景。     

RNA-binding proteins in RNA interference

Short RNAs (21–27 nt) silence genes that contain homologous nucleotide sequences; this is known as RNA silencing. This review considers the generation of short RNAs from their precursors: double-stranded RNAs, capable of inducing RNA interference, and hairpin RNAs, whose processing yields microRNAs, as well as the properties of RNA-binding domains that were initially identified in proteins operating in RNA interference. The interactions between these domains and known RNA-binding modules within proteins involved in RNA interference and microRNA generation are described.     

RNA interference in pain research

Within the course of only the last few years, RNA interference (RNAi) has been established as a standard technology for investigation of protein function and target validation. The present review summarizes recent progress made in the application of RNAi in neurosciences with special emphasis on pain research. RNAi is a straightforward method to generate loss-of-function phenotypes for any gene of interest. In mammals, silencing is induced by small interfering RNAs (siRNAs), which have been shown to surpass traditional antisense molecules. Due to its high specificity, RNAi has the potential for subtype selective silencing of even closely related genes. One of the major challenges for in vivo investigations of RNAi remains efficient delivery of siRNA molecules to the relevant tissues and cells, particularly to the central nervous system. Various examples will be given to demonstrate that intrathecal application of siRNAs is a suitable approach to analyse the function of receptors or other proteins that are hypothesized to play an important role in pain signalling. Intensive efforts are currently ongoing to solve remaining problems such as the risk of off-target effects, the stability of siRNA molecules and their efficient delivery to the CNS. RNAi has thus demonstrated that it is an extremely valuable tool for the development of new analgesic drugs.     

RNA-dependent RNA polymerase 6 is required for efficient hpRNA-induced gene silencing in plants

In plants, transgenes with inverted repeats are used to induce efficient RNA silencing, which is also frequently induced by highly transcribed sense transgenes. RNA silencing induced by sense transgenes is dependent on RNA-dependent RNA polymerase 6 (RDR6), which converts single-stranded (ss) RNA into double-stranded (ds) RNA. By contrast, it has been proposed that RNA silencing induced by self-complementary hairpin RNA (hpRNA) does not require RDR6, because the hpRNA can directly fold back on itself to form dsRNA. However, it is unclear whether RDR6 plays a role in hpRNA-induced RNA silencing by amplifying dsRNA to spread RNA silencing within the plant. To address the efficiency of hpRNA-induced RNA silencing in the presence or absence of RDR6, Wild type (WT, Col-0) and rdr6-11 Arabidopsis thaliana lines expressing green fluorescent protein (GFP) were generated and transformed with a GFP-RNA interference (RNAi) construct. Whereas most GFP-RNAi-transformed WT lines exhibited almost complete silencing of GFP expression in the T1 generation, various levels of GFP expression remained among the GFP-RNAi-transformed rdr6-11 lines. Homozygous expression of GFP-RNAi in the T3 generation was not sufficient to induce complete GFP silencing in several rdr6-11 lines. Our results indicate that RDR6 is required for efficient hpRNA-induced RNA silencing in plants.     

RNA干扰用于基因治疗的研究进展

RNA干扰(RNAi)是20世纪末才被人们认识和重视的一种通过双链RNA抵御病毒入侵或抑制转座子活动的生物防御机制。随着RNA干扰分子机制研究的深入及其应用研究的发展,人们发现RNA干扰技术在基因功能研究及人类疾病的基因治疗上具有广阔的应用前景。本文在简述RNAi分子机制的基础上,综述了RNAi在抗病毒治疗及抗肿瘤治疗方面的研究和应用概况。     

RNA干扰在疾病治疗方面的应用研究

RNA干扰是由双链RNA引起的序列特异的基因沉默现象。由于RNA干扰能在细胞组织及动物模型中沉默疾病相关基因,因此,RNA干扰也是各种疾病治疗的有效手段。在哺乳动物细胞内诱导RNA干扰可以通过导入小干扰RNA（siRNA）,或是以质粒、病毒为载体表达短的发夹RNA（shRNA）而实现。本文介绍了RNA干扰在疾病治疗方面的应用,并就其面临的挑战进行讨论。